(Q50954481)

26 March 2018

title

Comparative study of bioavailability and clinical efficacy of carbamazepine in epileptic patients (English)

1 reference

26 March 2018

1 reference

O Silpakit

1

1 reference

26 March 2018

M Amornpichetkoon

series ordinal

2

1 reference

26 March 2018

S Kaojarern

series ordinal

3

1 reference

26 March 2018

language of work or name

English

0 references

publication date

1 May 1997

1 reference

26 March 2018

Annals of Pharmacotherapy

published in

1 reference

26 March 2018

volume

31

1 reference

26 March 2018

issue

5

1 reference

26 March 2018

page(s)

548-552

1 reference

26 March 2018

Comparison of steady-state blood levels of two carbamazepine formulations

cites work

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100504

Clinically significant carbamazepine drug interactions: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100504

Pharmacokinetics: time-dependent changes--autoinduction of carbamazepine epoxidation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100504

Generic substitutions for antiepileptic drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100504

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100504

An exact confidence interval from untransformed data for the ratio of two formulation means

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100504

Single-drug therapy with carbamazepine in patients with epilepsy: serum levels and clinical effect.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F106002809703100504

10.1177/106002809703100504

21 January 2018

Identifiers

DOI

1 reference

26 March 2018

1 reference

26 March 2018